Redefining radiologic responses (RR) in solid tumors: Shall we brace ourselves for a post-RECIST era? Results from a randomized clinical trial (RCT) on neoadjuvant chemotherapy in high-risk soft-tissue sarcomas (HR-STS) of the trunk or extremities

被引：0
|
作者：
Vanzulli, Andrea
Vigorito, Raffaella
Buonomenna, Ciriaco
Palmerini, Emanuela
Quagliuolo, Vittorio
Broto, Javier Martin
Pousa, Antonio Lopez
Grignani, Giovanni
Brunello, Antonella
Blay, Jean-Yves
Diaz-Beveridge, Robert
Ferraresi, Virginia
Lugowska, Iwona A.
Pizzamiglio, Sara
Verderio, Paolo
Duroni, Valeria
Fontana, Valeria
Morosi, Carlo
Stacchiotti, Silvia
Gronchi, Alessandro
机构：
[1] Fdn IRCCS Ist Nazl Tumori Milano, Dept Radiol, Milan, Italy
[2] IRCCS Ist Ortoped Rizzoli Bologna, Osteoncol Bone & Soft Tissue Sarcomas & Innovat T, Bologna, Italy
[3] IRCCS Humanitas Res Hosp, Dept Surg, Rozzano, Italy
[4] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain
[5] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[6] Osped Citta Sci & Salute, Dept Canc Med, Turin, Italy
[7] IRCCS Ist Oncol Veneto IOV, Dept Oncol, Med Oncol Unit 1, Padua, Italy
[8] Ctr Leon Berard, Lyon, France
[9] Hosp Univ & Politecn La Fe, Dept Med Oncol, Valencia, Spain
[10] IRCCS Regina Elena Natl Canc Inst, Sarcomas & Rare Tumors Dept Unit, Rome, Italy
[11] Centrum Onkol Instytutim Marii Sklodowskiej Curie, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland
[12] Fdn IRCCS Ist Nazl Tumori Milano, Unit Bioinformat & Biostat, Milan, Italy
[13] IRCCS Osped Policlin San Martino, IST Ist Nazl Ric Cancro, Clin Trial Ctr, Genoa, Italy
[14] IRCCS Osped Policlin San Martino, IST Ist Nazl Ric Cancro, Dept Epidemiol, Genoa, Italy
[15] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[16] Fdn IRCCS Ist Nazl Tumori Milano, Dept Surg, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11553
引用
收藏
页数：1
相关论文
共 6 条
  • [1] Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial
    Vanzulli, A.
    Vigorito, R.
    Buonomenna, C.
    Palmerini, E.
    Quagliuolo, V.
    Broto, J. M.
    Pousa, A. Lopez
    Grignani, G.
    Brunello, A.
    Blay, J. -y.
    Beveridge, R. Diaz
    Ferraresi, V.
    Lugowska, I.
    Pizzamiglio, S.
    Verderio, P.
    Duroni, V.
    Fontana, V.
    Donati, D. M.
    Palassini, E.
    Bianchi, G.
    Bertuzzi, A.
    Buonadonna, A.
    Pasquali, S.
    Tos, A. P. Dei
    Casali, P. G.
    Morosi, C.
    Stacchiotti, S.
    Gronchi, A.
    ESMO OPEN, 2025, 10 (03)
  • [2] Impact of regional hyperthermia (RHT) on response to neo-adjuvant chemotherapy and survival of patients with high-risk soft-tissue sarcoma (HR-STS): Results of the randomized EORTC-ESHO intergroup trial (NCI-00003052)
    Issels, R.
    Lindner, L. H.
    Wendtner, C. M.
    Hohenberger, P.
    Reichardt, P.
    Daugaard, S.
    Mansmann, U.
    Hiddemann, W.
    Blay, J. Y.
    Verweij, J.
    EJC SUPPLEMENTS, 2009, 7 (03): : 2 - 2
  • [3] Full-dose neoadjuvant anthracycline plus ifosfamide chemotherapy is associated with a relapse free survival (RFS) and overall survival (OS) benefit in localized high-risk adult soft tissue sarcomas (STS) of the extremities and trunk wall: Interim analysis of a prospective randomized trial
    Gronchi, A.
    Ferrari, S.
    Quagliuolo, V.
    Martin Broto, J.
    Lopez-Pousa, A.
    Grignani, G.
    Ferraresi, V.
    Blay, J-Y.
    Rutkowski, P.
    Merlo, F. D.
    Marchesi, E.
    Ledesma, P.
    Tos, A. P. Dei
    Rosell, S. Bague
    Coindre, J-M.
    Morosi, C.
    Stacchiotti, S.
    Picci, P.
    Bruzzi, P.
    Casali, P. G.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Final results of a randomized clinical trial from the Italian Sarcoma Group, the Spanish Sarcoma Group (GEIS), the French Sarcoma Group (FSG), and the Polish Sarcoma Group (PSG).
    Gronchi, Alessandro
    Palmerini, Emanuela
    Quagliuolo, Vittorio
    Broto, Javier Martin
    Pousa, Antonio Lopez
    Grignani, Giovanni
    Brunello, Antonella
    Blay, Jean-Yves
    Beveridge, Robert Diaz
    Ferraresi, Virginia
    Lugowska, Iwona
    Merlo, Franco Domenico
    Fontana, Valeria
    Palassini, Elena
    Morosi, Carlo
    Stacchiotti, Silvia
    Dei Tos, Angelo Paolo
    Picci, Piero
    Bruzzi, Paolo
    Casali, Paolo Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Localized, high-risk soft tissue sarcomas (STS) of the extremities and trunk wall in adults: Three versus five cycles of full-dose anthracyclin and ifosfamide adjuvant chemotherapy: A phase III randomized trial from the Italian Sarcoma Group (ISG) and Spanish Sarcoma Group (GEIS)
    Gronchi, A.
    Frustaci, S.
    Mercuri, M.
    Broto, J. Martin
    Lopez-Pousa, A.
    Mariani, L.
    Verderio, P.
    Quagliuolo, V.
    Casali, P. G.
    Picci, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Results of the expanded cohort of myxoid liposarcoma of the randomized clinical trial from the Italian Sarcoma Group (ISG), the Spanish Sarcoma Group (GEIS), the French Sarcoma Group (FSG), and the Polish Sarcoma Group (PSG).
    Gronchi, Alessandro
    Palmerini, Emanuela
    Quagliuolo, Vittorio
    Broto, Javier Martin
    Lopez-Pousa, Antonio
    Grignani, Giovanni
    Brunello, Antonella
    Blay, Jean-Yves
    Beveridge, Robert Diaz
    Ferraresi, Virginia
    Lugowska, Iwona
    Pizzamiglio, Sara
    Verderio, Paolo
    Fontana, Valeria
    Donati, Davide Maria
    Palassini, Elena
    Stacchiotti, Silvia
    Miceli, Rosalba
    Tos, Angelo Paolo Dei
    Casali, Paolo Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
1